Form 4 for ULTA Ulta Beauty
Accepted 2024-03-21 00:00:00 ET · period of report 2024-03-19 · accession 0000897069-24-000732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-21 | 2024-03-19 | ULTA | Ryan Anita Jane | CHRO | M - OptEx | $239.71 | +2,852 | 5,807 | +97% | +$683.7K |
| DM | 2024-03-21 | 2024-03-19 | ULTA | Ryan Anita Jane | CHRO | S - Sale+OE | $525.25 | -3,102 | 3,257 | -49% | -$1.63M |
| DM | 2024-03-21 | 2024-03-19 | ULTA | Ryan Anita Jane | CHRO | M - OptEx | $0.00 | -2,852 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-19 | M | A | 1,068 | $348.73 | 4,023 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-19 | S | D | 552 | $526.15 | 2,705 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The prices actually received ranged from $525.775 to $526.330. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price. |
| 3 | Common | Common Stock | 2024-03-19 | S | D | 2,550 | $525.06 | 3,257 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The prices actually received ranged from $524.705 to $525.650. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price. |
| 4 | Common | Common Stock | 2024-03-19 | M | A | 1,784 | $174.45 | 5,807 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-03-19 | M | D | 1,068 | $0.00 | 0 | D | $348.73 · — to 2029-03-29 | 1,068 Common Stock | (F3) The options, representing an initial right to purchase a total of 1,068 shares, vesting in 25% annual increments beginning March 15, 2020 and each anniversary thereafter through March 15, 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-03-19 | M | D | 1,784 | $0.00 | 0 | D | $174.45 · — to 2030-03-27 | 1,784 Common Stock | (F4) The options, representing an initial right to purchase a total of 2,378 shares, vesting in 25% annual increments beginning March 15, 2021 and each anniversary thereafter through March 15, 2024. |